Laboratories

Publications

Update : 2017-06-27

Contents

  1. Original articles
  2. Reviews and book chapters

Original articles

2017

H. Katsushima, N. Fukuhara, S. Ichikawa, Y. Ota, K. Takeuchi, K. Ishizawa, H. Sasano, H. Harigae and R. Ichinohasama.
Non-biased and complete case registration of lymphoid leukemia and lymphoma for five years: a first representative index of Japan from an epidemiologically stable Miyagi Prefecture.
Leukemia & lymphoma, 58, 80-88 (2017)
S. Kujiraoka, T. Tsunematsu, Y. Sato, M. Yoshida, A. Ishikawa, R. Tohyama, M. Tanaka, Y. Kobayashi, T. Kondo, A. Ushio, K. Otsuka, M. Kurosawa, M. Saito, A. Yamada, R. Arakaki, H. Nagai, H. Nikai, K. Takeuchi, T. Nagao, Y. Miyamoto, N. Ishimaru and Y. Kudo.
Establishment and characterization of a clear cell odontogenic carcinoma cell line with EWSR1-ATF1 fusion gene.
Oral oncology, 69, 46-55 (2017)
Y. Kusano, M. Yokoyama, Y. Terui, N. Nishimura, Y. Mishima, K. Ueda, N. Tsuyama, H. Yamauchi, A. Takahashi, N. Inoue, K. Takeuchi and K. Hatake.
Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP treated patients with diffuse large B-cell lymphoma.
Blood cancer journal, in press (2017)
T. B. Nguyen, M. Sakata-Yanagimoto, Y. Asabe, D. Matsubara, J. Kano, K. Yoshida, Y. Shiraishi, K. Chiba, H. Tanaka, S. Miyano, K. Izutsu, N. Nakamura, K. Takeuchi, H. Miyoshi, K. Ohshima, T. Minowa, S. Ogawa, M. Noguchi and S. Chiba.
Identification of cell-type-specific mutations in nodal T-cell lymphomas.
Blood cancer journal, 7, e516 (2017)
T. Tamura, K. Kiura, T. Seto, K. Nakagawa, M. Maemondo, A. Inoue, T. Hida, H. Yoshioka, M. Harada, Y. Ohe, N. Nogami, H. Murakami, H. Kuriki, T. Shimada, T. Tanaka, K. Takeuchi and M. Nishio.
Three-year follow-up of an alectinib phase I/II study in ALK-positive non-small-cell lung cancer: AF-001JP.
Journal of clinical oncology, 35, 1515-1521 (2017)
N. Tsuyama, D. Ennishi, M. Yokoyama, S. Baba, R. Asaka, Y. Mishima, Y. Terui, K. Hatake and K. Takeuchi.
Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
Oncotarget, 8, 33487-33500 (2017)
N. Tsuyama, S. Sakata, S. Baba, Y. Mishima, N. Nishimura, K. Ueda, M. Yokoyama, Y. Terui, K. Hatake, M. Kitagawa, N. Ishizuka, N. Tomita and K. Takeuchi.
BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation.
Blood, in press (2017)
K. Yoshimura, N. Inui, M. Karayama, Y. Inoue, N. Enomoto, T. Fujisawa, Y. Nakamura, K. Takeuchi, H. Sugimura and T. Suda.
Successful crizotinib monotherapy in EGFR-mutant lung adenocarcinoma with acquired MET amplification after erlotinib therapy.
Respiratory medicine case reports, 20, 160-163 (2017)

Return to Top of Page

2016

S. T. Chang, S. W. Chen, C. H. Ho, C. C. Kuo, S. Sakata, K. Takeuchi and S. S. Chuang.
Immunophenotypic and genetic characteristics of diffuse large B-cell lymphoma in Taiwan.
Journal of the Formosan Medical Association, 115, 961-967 (2016)
A. Dobashi, N. Tsuyama, R. Asaka, Y. Togashi, K. Ueda, S. Sakata, S. Baba, K. Sakamoto, K. Hatake and K. Takeuchi.
Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type.
Genes, chromosomes & cancer, 55, 460-71 (2016)
A. Harada, M. Oguchi, Y. Terui, K. Takeuchi, M. Igarashi, T. Kozuka, K. Harada, T. Uno and K. Hatake.
Radiation therapy for localized duodenal low-grade follicular lymphoma.
Journal of radiation research, 57, 412-417 (2016)
Y. Harada, T. Koyama, K. Takeuchi, K. Shoji, K. Hoshi and Y. Oyama.
NUT midline carcinoma mimicking a germ cell tumor: a case report.
BMC Cancer, 16, 895 (2016)
A. Horiike, K. Takeuchi, T. Uenami, Y. Kawano, A. Tanioto, K. Kaburaki, Y. Tambo, K. Kudo, N. Yanagitani, F. Ohyanagi, N. Motoi, Y. Ishikawa, T. Horai and M. Nishio.
Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancer.
Lung Cancer, 93, 43-46 (2016)
M. Inoue, H. Toki, J. Matsui, Y. Togashi, A. Dobashi, R. Fukumura, Y. Gondo, O. Minowa, N. Tanaka, S. Mori, K. Takeuchi and T. Noda.
Mouse models for ROS1-fusion-positive lung cancers and their application to the analysis of multikinase inhibitor efficiency.
Carcinogenesis, 37, 452-60 (2016)
K. Kataoka, Y. Shiraishi, Y. Takeda, S. Sakata, M. Matsumoto, S. Nagano, T. Maeda, Y. Nagata, A. Kitanaka, S. Mizuno, H. Tanaka, K. Chiba, S. Ito, Y. Watatani, N. Kakiuchi, H. Suzuki, T. Yoshizato, K. Yoshida, M. Sanada, H. Itonaga, Y. Imaizumi, Y. Totoki, W. Munakata, H. Nakamura, N. Hama, K. Shide, Y. Kubuki, T. Hidaka, T. Kameda, K. Masuda, N. Minato, K. Kashiwase, K. Izutsu, A. Takaori-Kondo, Y. Miyazaki, S. Takahashi, T. Shibata, H. Kawamoto, Y. Akatsuka, K. Shimoda, K. Takeuchi, T. Seya, S. Miyano and S. Ogawa.
Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers.
Nature, 534, 402-6 (2016)
R. Katayama, T. Sakashita, N. Yanagitani, H. Ninomiya, A. Horiike, L. Friboulet, J. F. Gainor, N. Motoi, A. Dobashi, S. Sakata, Y. Tambo, S. Kitazono, S. Sato, S. Koike, A. J. Iafrate, M. Mino-Kenudson, Y. Ishikawa, A. T. Shaw, J. A. Engleman, K. Takeuchi, M. Nishio and N. Fujita.
P-glycoprotein mediates ceritinib resistance in anaplastic lymphoma kinase-rearranged non-small cell lung cancer.
EBioMedicine, 3, 54-66 (2016)
M. Koyama, T. Terauchi, M. Koizumi, H. Tanaka and K. Takeuchi.
Sinonasal oncocytic Schneiderian papilloma accompanied by intravascular lymphoma: A case report on FDG-PET/CT imaging.
Medicine, 95, e4646 (2016)
D. Kurita, K. Takeuchi, S. Kobayashi, A. Hojo, Y. Uchino, M. Sakagami, S. Ohtake, H. Takahashi, K. Miura, N. Iriyama, M. Sugitani, H. Miyoshi, Y. Hatta, K. Ohshima and M. Takei.
A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.
Virchows Archiv, 469, 471-6 (2016)
H. Kusano, Y. Togashi, J. Akiba, F. Moriya, K. Baba, N. Matsuzaki, Y. Yuba, Y. Shiraishi, H. Kanamaru, N. Kuroda, S. Sakata, K. Takeuchi and H. Yano.
Two cases of renal cell carcinoma harboring a novel STRN-ALK fusion gene.
American journal of surgical pathology, 40, 761-9 (2016)
K. Sakamoto, H. Nakasone, Y. Togashi, S. Sakata, N. Tsuyama, S. Baba, A. Dobashi, R. Asaka, C. C. Tsai, S. S. Chuang, K. Izutsu, Y. Kanda and K. Takeuchi.
ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern.
International journal of hematology, 103, 399-408 (2016)
Y. Shigematsu, M. Matsuura, N. Nishimura, N. Tsuyama, K. Takeuchi, Y. Terui, N. Takeshima and K. Hatake.
Intravascular large B-cell lymphoma of bilateral ovaries and the uterus in an asymptomatic patient with a t(11;22)(q23;q11) constitutional translocation.
Internal Medicine, 55, 3169-74 (2016)
K. Takeuchi, Y. Togashi, Y. Kamihara, T. Fukuyama, H. Yoshioka, A. Inoue, H. Katsuki, K. Kiura, K. Nakagawa, T. Seto, M. Maemondo, T. Hida, M. Harada, Y. Ohe, N. Nogami, N. Yamamoto, M. Nishio and T. Tamura.
Prospective and clinical validation of ALK immunohistochemistry: Results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study).
Annals of oncology, 27, 185-192 (2016)

Return to Top of Page

2015

T. Aoki, R. Suzuki, Y. Kuwatsuka, S. Kako, K. Fujimoto, J. Taguchi, T. Kondo, K. Ohata, T. Ito, Y. Kamoda, T. Fukuda, T. Ichinohe, K. Takeuchi, K. Izutsu and J. Suzumiya.
Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm.
Blood, 125, 3559-62 (2015)
K. Kataoka, Y. Nagata, A. Kitanaka, Y. Shiraishi, T. Shimamura, J. I. Yasunaga, Y. Totoki, K. Chiba, A. Sato-Otsubo, G. Nagae, R. Ishii, S. Muto, S. Kotani, Y. Watatani, J. Takeda, M. Sanada, H. Tanaka, H. Suzuki, Y. Sato, Y. Shiozawa, T. Yoshizato, K. Yoshida, H. Makishima, M. Iwanaga, G. Ma, K. Nosaka, M. Hishizawa, H. Itonaga, Y. Imaizumi, W. Munakata, H. Ogasawara, T. Sato, K. Sasai, K. Muramoto, M. Penova, T. Kawaguchi, H. Nakamura, N. Hama, K. Shide, Y. Kubuki, T. Hidaka, T. Kameda, T. Nakamaki, K. Ishiyama, S. Miyawaki, S. S. Yoon, K. Tobinai, Y. Miyazaki, A. Takaori-Kondo, F. Matsuda, K. Takeuchi, O. Nureki, H. Aburatani, T. Watanabe, T. Shibata, M. Matsuoka, S. Miyano, K. Shimoda and S. Ogawa.
Integrated molecular analysis of adult T cell leukemia/lymphoma.
Nature genetics, 47, 1304-15 (2015)
S. Y. Lin, S. S. Chuang, J. Y. Jhuang, K. Sakamoto, K. Takeuchi, A. Bahrami and C. C. Tsai.
ALK positive large B-cell lymphoma with a massive neutrophilic infiltrate: report of a case mimicking epithelioid inflammatory myofibroblastic tumour.
Journal of clinical pathology, 68, 496-498 (2015)
T. Nakada, S. Okumura, H. Kuroda, H. Uehara, M. Mun, K. Takeuchi and K. Nakagawa.
Imaging characteristics in ALK fusion-positive lung adenocarcinomas by using HRCT.
Annals of thoracic and cardiovascular surgery, 21, 102-108 (2015)
H. Nitta, Y. Terui, M. Yokoyama, Y. Mishima, N. Nishimura, K. Ueda, Y. Kusano, N. Tsuyama, K. Takeuchi, Y. Kanda and K. Hatake.
Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma.
Haematologica, 100, 87-90 (2015)
H. Sakurai, K. J. Sugimoto, A. Shimada, H. Imai, M. Wakabayashi, Y. Sekiguchi, Y. Ota, K. Izutsu, K. Takeuchi, N. Komatsu and M. Noguchi.
Primary CNS CCND1/MYC-positive double-hit B-cell lymphoma: A case report and review of the literature.
Journal of clinical oncology, 33, e77-e83 (2015)
N. Tomita, F. Kodama, N. Tsuyama, S. Sakata, K. Takeuchi, D. Ishibashi, S. Koyama, Y. Ishii, W. Yamamoto, H. Takasaki, M. Hagihara, H. Kuwabara, M. Tanaka, C. Hashimoto, E. Yamazaki, H. Koharazawa, K. Fujimaki, R. Sakai, S. Fujisawa and Y. Ishigatsubo.
Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.
Hematological oncology, 33, 9-14 (2015)

Return to Top of Page

2014

Chang, S.T., Lu, Y.H., Lu, C.L., Weng, S.F., Lin, S.H., Kuo, S.Y., Chuang, Y.T., Takeuchi, K., Ohshima, K., Chuang, S.S.
Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time.
J Clin Pathol, 67, 326-332 (2014)
Hashimoto, T., Fujimoto, M., Nishikori, M., Takeuchi, K., Kimura, M., Nakajima, N., Miyagawa-Hayashino, A., Takaori-Kondo, A., Haga, H.
Plasmacytic ALK-positive large B-cell lymphoma: a potential mimic of extramedullary plasmacytoma.
Pathol Int, 64, 292-294 (2014)
Hong, M., Kim, R.N., Song, J.Y., Choi, S.J., Oh, E., Lira, M.E., Mao, M., Takeuchi, K., Han, J., Kim, J., Choi, Y.L.
HIP1-ALK, a novel fusion protein identified in lung adenocarcinoma.
J Thorac Oncol, 9, 419-422 (2014)
Katayama, R., Friboulet, L., Koike, S., Lockerman, E.L., Khan, T.M., Gainor, J.F., Iafrate, A.J., Takeuchi, K., Taiji, M., Okuno, Y., Fujita, N., Engelman, J.A., Shaw, A.T.
Two novel ALK mutations mediate acquired resistance to the next-generation AKL inhibitor alectinib.
Clin Cancer Res, 20, 5686-5696 (2014)
Kozu, Y., Isaka, M., Ohde, Y., Takeuchi, K., Nakajima, T.
Epithelioid inflammatory myofibroblastic sarcoma arising in the pleural cavity.
Gen Thorac Cardiovasc Surg, 62, 191-194 (2014)
Lee, S.E., Kang, S.Y., Takeuchi, K., Ko, Y.H.
Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma.
Hematol Oncol, 32, 221-224 (2014)
Nakamoto-Matsubara, R., Sakata-Yanagimoto, M., Enami, T., Yoshida, K., Yanagimoto, S., Shiozawa, Y., Nanmoku, T., Satomi, K., Muto, H., Obara, N., Kato, T., Kurita, N., Yokoyama, Y., Izutsu, K., Ota, Y., Sanada, M., Shimizu, S., Komeno, T., Sato, Y., Ito, T., Kitabayashi, I., Takeuchi, K., Nakamura, N., Ogawa, S., Chiba, S.
Detection of the G17V RHOA mutation in angioimmunoblastic T-Cell lymphoma and related lymphomas using quantitative allele-specific PCR.
PLoS One, 9, e109714 (2014)
Sakata-Yanagimoto, M., Enami, T., Yoshida, K., Shiraishi, Y., Ishii, R., Miyake, Y., Muto, H., Tsuyama, N., Sato-Otsubo, A., Okuno, Y., Sakata, S., Kamada, Y., Nakamoto-Matsubara, R., Tran, N.B., Izutsu, K., Sato, Y., Ohta, Y., Furuta, J., Shimizu, S., Komeno, T., Ito, T., Noguchi, M., Noguchi, E., Sanada, M., Chiba, K., Tanaka, H., Suzukawa, K., Nanmoku, T., Hasegawa, Y., Nureki, O., Miyano, S., Nakamura, N., Takeuchi, K., Ogawa, S., Chiba, S.
Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.
Nat Genet, 46, 171-175 (2014)
Sugiyama, H., Maeda, Y., Nishimori, H., Yamasuji, Y., Matsuoka, K.I., Fujii, N., Kondo, E., Shinagawa, K., Tanaka, T., Takeuchi, K., Teshima, T., Tanimoto, M.
Mammalian target of rapamycin inhibitors permit regulatory T cell reconstitution and inhibit experimental chronic graft-versus-host disease.
Biol Blood Marrow Transplant, 20, 183-191 (2014)
Yamamoto, W., Nakamura, N., Tomita, N., Takeuchi, K., Ishii, Y., Takahashi, H., Watanabe, R., Takasaki, H., Motomura, S., Kobayashi, S., Yokose, T., Ishigatsubo, Y., Sakai, R.
HLA-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B cell lymphoma treated by R-CHOP therapy: Retrospective cohort study.
Leuk Lymphoma, 55, 2721-2727 (2014)

このページのTOPへ

2013

Awano, N., Inomata, M., Sonoda, Y., Kondoh, K., Ono, R., Moriya, A., Ando, T., Kumasaka, T., Takemura, T., Takeuchi, K., Ikushima, S.
A case of multicentric castleman's disease of mixed-type, which showed constellation of symptoms, i.e., thrombocytopenia, anasarca, anemia, fever, myelofibrosis, and lymphadenopathy.
J Clin Exp Hematop, 53, 101-105 (2013)
Fukumura, K., Yamashita, Y., Kawazu, M., Sai, E., Fujiwara, S., Nakamura, N., Takeuchi, K., Ando, M., Miyazono, K., Ueno, T., Ozawa, K., Mano, H.
STK10 missense mutations associated with anti-apoptotic function.
Oncol Rep, 30, 1542-1548 (2013)
Kawabata, K.C., Ehata, S., Komuro, A., Takeuchi, K., Miyazono, K.
TGF-β-induced apoptosis of B-cell lymphoma Ramos cells through reduction of MS4A1/CD20.
Oncogene, 32, 2096-2106 (2013)
Kawazu, M., Ueno, T., Kontani, K., Ogita, Y., Ando, M., Fukumura, K., Yamato, A., Soda, M., Takeuchi, K., Miki, Y., Yamaguchi, H., Yasuda, T., Naoe, T., Yamashita, Y., Katada, T., Choi, Y.L., Mano, H.
Transforming mutations of RAC guanosine triphosphatases in human cancers.
Proc Natl Acad Sci U S A, 110, 3029-3034 (2013)
Li, J., Yin, W.H., Takeuchi, K., Guan, H., Huang, Y.H., Chan, J.K.
Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review.
Diagn Pathol, 8, 147 (2013)
Matsuda, I., Takeuchi, K., Mizuguchi, S., Kaji, M., Ueda, K., Teramura, K., Hirota, S.
A case of synchronous bilateral lung cancers: EML4-ALK positive adenocarcinoma in the right lung and adenocarcinoma in situ (the former bronchioloalveolar carcinoma) in the left lung.
BMC Pulm Med, 13, 25 (2013)
Miyanaga, A., Shimizu, K., Noro, R., Seike, M., Kitamura, K., Kosaihira, S., Minegishi, Y., Shukuya, T., Yoshimura, A., Kawamoto, M., Tsuchiya, S., Hagiwara, K., Soda, M., Takeuchi, K., Yamamoto, N., Mano, H., Ishikawa, Y., Gemma, A.
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4-ALK-rearranged non-small-cell lung cancer harbored coexisting EGFR mutation.
BMC Cancer, 13, 262 (2013)
Ninomiya, H., Kato, M., Sanada, M., Takeuchi, K., Inamura, K., Motoi, N., Nagano, H., Nomura, K., Sakao, Y., Okumura, S., Mano, H., Ogawa, S., Ishikawa, Y.
Allelotypes of lung adenocarcinomas featuring ALK fusion demonstrate fewer onco- and suppressor gene changes.
BMC Cancer, 13, 8 (2013)
Nishida, Y., Takeuchi, K., Tsuda, K., Ugai, T., Sugihara, H., Yamakura, M., Takeuchi, M., Matsue, K.
Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12.
Eur J Haematol, 91, 179-182 (2013)
Osako, T., Takeuchi, K., Horii, R., Iwase, T., Akiyama, F.
Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis.
Histopathology, 63, 509-519 (2013)
Sekiguchi, Y., Matsuzawa, N., Shimada, A., Imai, H., Wakabayashi, M., Sugimoto, K., Nakamura, N., Sawada, T., Izutsu, K., Takeuchi, K., Ohta, Y., Komatsu, N., Noguchi, M.
Angioimmunoblastic T-cell lymphoma with intramedullary production of platelet-derived growth factor and possibly complicating myelofibrosis: report of a case with review of the literature.
Int J Hematol, 98, 250-257 (2013)
Sekiguchi, Y., Yoshikawa, H., Shimada, A., Imai, H., Wakabayashi, M., Sugimoto, K., Nakamura, N., Sawada, T., Takeuchi, K., Ohta, Y., Komatsu, N., Noguchi, M.
Primary Hepatic Circumscribed Burkitt's Lymphoma that Developed after Acute Hepatitis B : Report of a Case with a Review of the Literature.
J Clin Exp Hematop, 53, 167-173 (2013)
Seto, T., Kiura, K., Nishio, M., Nakagawa, K., Maemondo, M., Inoue, A., Hida, T., Yamamoto, N., Yoshioka, H., Harada, M., Ohe, Y., Nogami, N., Takeuchi, K., Shimada, T., Tanaka, T., Tamura, T.
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study.
Lancet Oncol, 14, 590-598 (2013)
Sugimoto, K.J., Shimada, A., Wakabayashi, M., Imai, H., Sekiguchi, Y., Nakamura, N., Sawada, T., Ota, Y., Takeuchi, K., Ito, Y., Kimura, H., Komatsu, N., Noguchi, M.
A probable identical Epstein-Barr virus clone-positive composite lymphoma with aggressive natural killer-cell leukemia and cytotoxic T-cell lymphoma.
Int J Clin Exp Pathol, 7, 411-417 (2013)
Suzuki, K., Terui, Y., Nishimura, N., Mishima, Y., Sakajiri, S., Yokoyama, M., Takahashi, S., Tsuyama, N., Takeuchi, K., Hatake, K.
Prognostic value of C-reactive protein, lactase dehydrogenase and anemia in recurrent or refractory aggressive lymphoma.
Jpn J Clin Oncol, 43, 37-44 (2013)
Suzuki, K., Terui, Y., Yokoyama, M., Ueda, K., Nishimura, N., Mishima, Y., Sakajiri, S., Tsuyama, N., Takeuchi, K., Hatake, K.
Prognostic value of high thymidine kinase activity in previously untreated diffuse large B-cell lymphoma patients treated by R-CHOP.
Leuk Lymphoma, 54, 2412-2417 (2013)
Takahashi, H., Tomita, N., Sakata, S., Tsuyama, N., Hashimoto, C., Ohshima, R., Matsuura, S., Ogawa, K., Yamamoto, W., Kameda, Y., Enaka, M., Inayama, Y., Kasahara, M., Takekawa, Y., Onoda, N., Motomura, S., Ishigatsubo, Y., Takeuchi, K.
Prognostic significance of programmed cell death-1-positive cells in follicular lymphoma patients may alter in the rituximab era.
Eur J Haematol, 90, 286-290 (2013)
Takamochi, K., Takeuchi, K., Hayashi, T., Oh, S., Suzuki, K.
A rational diagnostic algorithm for the identification of ALK rearrangement in lung cancer: A comprehensive study of surgically treated Japanese patients.
PLoS One, 8, e69794 (2013)
Takeuchi, K.
Interpretation of anti-ALK immunohistochemistry results.
J Thorac Oncol, 8, e67-68 (2013)
Takeuchi, K., Sakata, S., Asaka, R., Tsuyama, N., Dobashi, A., Noguchi, M.
A low-grade B-cell lymphoma with prolymphocytic/paraimmunoblastic proliferation and IRF4 rearrangement.
Haematologica, 98, e32-35 (2013)
Ueda, K., Terui, Y., Yokoyama, M., Sakajiri, S., Nishimura, N., Tsuyama, N., Takeuchi, K., Hatake, K.
Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy.
Leuk Lymphoma, 54, 1928-1933 (2013)
Yamamoto, E., Tomita, N., Sakata, S., Tsuyama, N., Takeuchi, K., Nakajima, Y., Miyashita, K., Tachibana, T., Takasaki, H., Tanaka, M., Hashimoto, C., Koharazawa, H., Fujimaki, K., Taguchi, J., Harano, H., Motomura, S., Ishigatsubo, Y.
The MIB-1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy.
Cancer Sci, 104, 1670-1674 (2013)
Yokoyama, M., Terui, Y., Takeuchi, K., Nara, E., Nakano, K., Ueda, K., Nishimura, N., Mishima, Y., Sakajiri, S., Tsuyama, N., Ozawa, K., Hatake, K.
Infusion rate escalation study of rituximab in patients with CD20+ B-cell lymphomas: A single institution analysis in Japan.
ISRN Oncol, 2013:863909 (2013)

このページのTOPへ

2012

Awano, N., Inomata, M., Kondoh, K., Satake, K., Kamiya, H., Moriya, A., Ando, T., Kumasaka, T., Takemura, T., Takeuchi, K., Ikushima, S.
Mixed-type multicentric Castleman's disease developing during a 17-year follow-up of sarcoidosis.
Internal medicine, 51, 3061-3066 (2012)
Mishima, Y., Terui, Y., Yokoyama, M., Nishimura, N., Sakajiri, S., Ueda, K., Kuboki, Y., Nakano, K., Suzuki, K., Nara, E., Tsuyama, N., Takeuchi, K., Oguchi, M., Hatake, K.
R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma.
Exp Hematol Oncol, 1, 30 (2012)
Ota, Y., Takeuchi, H., Kurokawa, M., Fukayama, M.
Small lymphocytic lymphoma presenting as multiple lymphomatous polyposis.
J Clin Exp Pathol, 2, 132 (2012)
Goyama, S., Takeuchi, K., Kanda, Y., Nannya, Y., Chiba, S., Fukayama, M., Kurokawa, M.
Post-transplant endothelial disorder after hematopoietic SCT: a blinded autopsy study.
Bone Marrow Transplant, 47, 1243-1245 (2012)
Ishii, Y., Tomita, N., Sakata, S., Takeuchi, K., Tateishi, U., Watanabe, R., Sakai, R., Ishigatsubo, Y.
Maximum standard uptake value at the biopsy site during F-fluorodeoxyglucose positron emission tomography does not predict the proliferation potential of tumor cells in extranodal natural killer/T cell lymphoma, nasal type.
Acta Haematol, 128, 110-112 (2012)
Kimura, H., Nakajima, T., Takeuchi, K., Soda, M., Mano, H., Iizasa, T., Matsui, Y., Yoshino, M., Shingyoji, M., Itakura, M., Itami, M., Ikebe, D., Yokoi, S., Kageyama, H., Ohira, M., Nakagawara, A.
ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity.
Lung Cancer, 75, 66-72 (2012)
Nishimori, H., Maeda, Y., Teshima, T., Sugiyama, H., Kobayashi, K., Yamasuji, Y., Kadohisa, S., Uryu, H., Takeuchi, K., Tanaka, T., Yoshino, T., Iwakura, Y., Tanimoto, M.
Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17.
Blood, 119, 285-295 (2012)
Nomoto, J., Hiramoto, N., Kato, M., Sanada, M., Maeshima, A.M., Taniguchi, H., Hosoda, F., Asakura, Y., Munakata, W., Sekiguchi, N., Maruyama, D., Watanabe, T., Nakagama, H., Takeuchi, K., Tobinai, K., Ogawa, S., Kobayashi, Y.
Deletion of the TNFAIP3/A20 gene detected by FICTION analysis in classical Hodgkin lymphoma.
BMC Cancer, 12, 457 (2012)
Soda, M., Isobe, K., Inoue, A., Maemondo, M., Oizumi, S., Fujita, Y., Gemma, A., Yamashita, Y., Ueno, T., Takeuchi, K., Choi, Y.L., Miyazawa, H., Tanaka, T., Hagiwara, K., Mano, H.
A prospective PCR-based screening for the EML4-ALK oncogene in non-small cell lung cancer.
Clin Cancer Res, 18, 5682-5689 (2012)
Sugawara, E., Togashi, Y., Kuroda, N., Sakata, S., Hatano, S., Asaka, R., Yuasa, T., Yonese, J., Kitagawa, M., Mano, H., Ishikawa, Y., Takeuchi, K.
Identification of anaplastic lymphoma kinase fusions in renal cancer.
Cancer, 118, 4427-4436 (2012)
Takeuchi, K., Soda, M., Togashi, Y., Suzuki, R., Sakata, S., Hatano, S., Asaka, R., Hamanaka, W., Ninomiya, H., Uehara, H., Lim Choi, Y., Satoh, Y., Okumura, S., Nakagawa, K., Mano, H., Ishikawa, Y.
RET, ROS1 and ALK fusions in lung cancer.
Nat Med, 18, 378-381 (2012)
Terasako, K., Oshima, K., Wada, H., Ishihara, Y., Kawamura, K., Sakamoto, K., Ashizawa, M., Sato, M., Machishima, T., Nakasone, H., Kimura, S., Kikuchi, M., Okuda, S., Kako, S., Yamazaki, R., Takeuchi, K., Nishida, J., Yamada, S., Tanaka, O., Kanda, Y.
Fulminant hepatic failure caused by adenovirus infection mimicking peliosis hepatitis on abdominal computed tomography images after allogeneic hematopoietic stem cell transplantation.
Intern Med, 51, 405-411 (2012)
Togashi, Y., Soda, M., Sakata, S., Sugawara, E., Hatano, S., Asaka, R., Nakajima, T., Mano, H., Takeuchi, K.
KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only.
PLoS One, 7, e31323 (2012)
Tomita, N., Yokoyama, M., Yamamoto, W., Watanabe, R., Shimazu, Y., Masaki, Y., Tsunoda, S., Hashimoto, C., Murayama, K., Yano, T., Okamoto, R., Kikuchi, A., Tamura, K., Sato, K., Sunami, K., Shibayama, H., Takimoto, R., Ohshima, R., Hatta, Y., Moriuchi, Y., Kinoshita, T., Yamamoto, M., Numata, A., Ishigatsubo, Y., Takeuchi, K.
Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era.
Cancer Sci, 103, 245-251 (2012)
Yamamoto, M., Takeuchi, K., Shimoji, M., Maniwa, T., Isaka, M., Nakagawa, K., Ohde, Y., Kondo, H., Nakajima, T.
Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: A novel ALK fusion gene?
Cancer Sci, 103, 390-392 (2012)
Yao, R., Natsume, Y., Saiki, Y., Shioya, H., Takeuchi, K., Yamori, T., Toki, H., Aoki, I., Saga, T., Noda, T.
Disruption of Tacc3 function leads to in vivo tumor regression.
Oncogene, 31, 135-148 (2012)

このページのTOPへ

2011

Kijima, T., Takeuchi, K., Tetsumoto, S., Shimada, K., Takahashi, R., Hirata, H., Nagatomo, I., Hoshino, S., Takeda, Y., Kida, H., Goya, S., Tachibana, I., Kawase, I.
Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer.
Cancer Sci, 102, 1602-1604 (2011)
Mishima, Y., Terui, Y., Takeuchi, K., Matsumoto-Mishima, Y., Matsusaka, S.
The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations.
Blood Cancer J, 1, e15 (2011)
Okuda, C., Kim, Y.H., Takeuchi, K., Togashi, Y., Masago, K., Sakamori, Y., Mio, T., Mishima, M.
Successful treatment with pemetrexed in a patient with mucinous bronchioloalveolar carcinoma: long-term response duration with mild toxicity.
J Thorac Oncol, 6, 641-642 (2011)
Tachibana, T., Tomita, N., Furuya, M., Yamanaka, S., Takeuchi, K., Nakamura, N., Fujita, H., Ishigatsubo, Y.
Aberrant CD20 Expression in Angioimmunoblastic T-cell Lymphoma.
Intern Med, 50, 495-499 (2011)
Takeuchi, K., Soda, M., Togashi, Y., Ota, Y., Sekiguchi, Y., Hatano, S., Asaka, R., Noguchi, M., Mano, H.
Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma.
Haematologica, 96, 464-467 (2011)
Takeuchi, K., Soda, M., Togashi, Y., Sugawara, E., Hatano, S., Asaka, R., Okumura, S., Nakagawa, K., Mano, H., Ishikawa, Y.
Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK-fusion identification.
Clin Cancer Res, 17, 3341-3348 (2011)
Tanimoto, T., Matayoshi, T., Yagasaki, F., Takeuchi, K., Kami, M.
Safety and efficacy of zoledronic acid in multiple myeloma.
Lancet, 377, 2178 (2011)
Watanabe, N., Noh, J.Y., Narimatsu, H., Takeuchi, K., Yamaguchi, T., Kameyama, K., Kobayashi, K., Kami, M., Kubo, A., Kunii, Y., Shimizu, T., Mukasa, K., Otsuka, F., Miyara, A., Minagawa, A., Ito, K.
Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24 553 patients with Hashimoto's disease.
Br J Haematol, 153, 236-243 (2011)
Watanabe, T., Tobinai, K., Shibata, T., Tsukasaki, K., Morishima, Y., Maseki, N., Kinoshita, T., Suzuki, T., Yamaguchi, M., Ando, K., Ogura, M., Taniwaki, M., Uike, N., Takeuchi, K., Nawano, S., Terauchi, T., Hotta, T.
Phase II/III study of R-CHOP-21 versus R-CHOP-14 for untreated indolent B-Cell non-Hodgkin's lymphoma: JCOG 0203 Trial.
J Clin Oncol, 29, 3990-3998 (2011)

このページのTOPへ

2010

Asai, H., Yokoyama, M., Terui, Y., Ennishi, D., Takeuchi, K., Hatake, K.
Is statin use really associated with efficacy of rituximab?
J Clin Oncol, 28, e424-425; author reply e427-428 (2010)
Choi, Y.L., Soda, M., Yamashita, Y., Ueno, T., Takashima, J., Nakajima, T., Yatabe, Y., Takeuchi, K., Hamada, T., Haruta, H., Ishikawa, Y., Kimura, H., Mitsudomi, T., Tanio, Y., Mano, H.
EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.
N Engl JMed, 363, 1734-1739 (2010)
Ennishi, D., Asai, H., Maeda, Y., Shinagawa, K., Ikeda, K., Yokoyama, M., Terui, Y., Takeuchi, K., Yoshino, T., Matsuo, K., Hatake, K., Tanimoto, M.
Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.
Ann Oncol, 21, 1217-1221 (2010)
Hiramatsu, M., Ninomiya, H., Inamura, K., Nomura, K., Takeuchi, K., Satoh, Y., Okumura, S., Nakagawa, K., Yamori, T., Matsuura, M., Morikawa, T., Ishikawa, Y.
Activation status of receptor tyrosine kinase downstream pathways in primary lung adenocarcinoma with reference of KRAS and EGFR mutations.
Lung Cancer, 70, 94-102 (2010)
Hoshi, R., Furuta, N., Horai, T., Takeuchi, K., Ishikawa, Y., Satoh, Y.
Implications for differential diagnosis of lung cancer-associated lymphadenopathy in lymphoepithelioid cell lymphoma (Lennert's lymphoma) arising simultaneously with lung cancer: a case report.
Acta Cytol, 54, 197-201 (2010)
Hyo, R., Tomita, N., Takeuchi, K., Aoshima, T., Fujita, A., Kuwabara, H., Hashimoto, C., Takemura, S., Taguchi, J., Sakai, R., Fujita, H., Fujisawa, S., Ogawa, K., Motomura, S., Suzuki, R., Ishigatsubo, Y.
The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma.
Hematol Oncol, 28, 27-32 (2010)
Ichinohasama, R., Oji, Y., Yokoyama, H., Takeuchi, K., Fujiwara, T., Ishizawa, K., Taniguchi, O., Tsuboi, A., Oka, Y., Sugiyama, H.
Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide.
Cancer Sci, 101, 1089-1092 (2010)
Jokoji, R., Yamasaki, T., Minami, S., Komuta, K., Sakamaki, Y., Takeuchi, K., Tsujimoto, M.
Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma.
J Clin Pathol, 63, 1066-1070 (2010)
Kodaira, M., Takahashi, S., Takeuchi, K., Yuasa, T., Saotome, T., Yonese, J., Fukui, I., Hatake, K.
Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma.
Ann Oncol, 21, 1563-1565 (2010)
Kodaira, M., Takahashi, S., Yamada, S., Ueda, K., Mishima, Y., Takeuchi, K., Yamamoto, N., Ishikawa, Y., Yokoyama, M., Saotome, T., Terui, Y., Hatake, K.
Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy.
Ann Oncol, 21, 1163-1167 (2010)
Mano, H., Takeuchi, K.
EML4-ALK fusion in lung.
Am J Pathol, 176, 1552-1553; author reply 1553-1554 (2010)
Nakajima, T., Kimura, H., Takeuchi, K., Soda, M., Mano, H., Yasufuku, K., Iizasa, T.
Treatment of lung cancer with an ALK inhibitor after EML4-ALK fusion gene detection using endobronchial ultrasound-guided transbronchial needle aspiration.
J Thorac Oncol, 5, 2041-2043 (2010)
Nishimori, H., Takahashi, S., Kiura, K., Ennishi, D., Kobayashi, T., Sano, K., Shinozaki, E., Yokoyama, M., Mishima, Y., Terui, Y., Chin, K., Mizunuma, N., Ito, Y., Nishimura, S., Takeuchi, K., Ishikawa, Y., Oguchi, M., Tanimoto, M., Hatake, K.
Cancer of unknown primary site:a review of 28 cases and the efficacy of cisplatin/docetaxel therapy at a single institute in Japan.
Acta Med Okayama, 64, 285-291 (2010)
Sakairi, Y., Nakajima, T., Yasufuku, K., Ikebe, D., Kageyama, H., Soda, M., Takeuchi, K., Itami, M., Iizasa, T., Yoshino, I., Mano, H., Kimura, H.
EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration.
Clin Cancer Res, 16, 4938-4945 (2010)
Tachibana, T., Tomita, N., Furuya, M., Yamanaka, S., Takeuchi, K., Nakamura, N., Fujita, H., Ishigatubo, Y.
Aberrant CD20 expression in angioimmunoblastic T-cell lymphoma.
Intern Med, in press (2010)
Takeuchi, K., Soda, M., Togashi, Y., Ota, Y., Sekiguchi, Y., Hatano, S., Asaka, R., Noguchi, M., Mano, H.
Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma.
Haematologica, in press (2010)
Takeuchi, K., Yokoyama, M., Ishizawa, S., Terui, Y., Nomura, K., Marutsuka, K., Nunomura, M., Fukushima, N., Yagyuu, T., Nakamine, H., Akiyama, F., Hoshi, K., Matsue, K., Hatake, K., Oshimi, K.
Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation.
Blood, 116, 5631-5637 (2010)
Tsuji, H., Tamura, M., Yokoyama, M., Takeuchi, K., Mimura, T.
Ocular involvement by epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: a new disease entity in the world health organization classification.
Arch Ophthalmol, 128, 258-259 (2010)
Watanabe, N., Noh, J.Y., H., N., Takeuchi, K., Yamaguchi, T., Kameyama, K., Kobayashii, K., Kami, M., Kubo, A., Kunii, Y., Shimizu, T., Mukasa, K., Otsuka, F., Miyara, A., Minagawa, A., Ito, K., Ito, K.
Clinicopatholgical features of 171 cases of primary thyroid lymphoma: a long-term study involving 24,553 patients with Hashimoto's disease.
Br J Haematol, in press (2010)
Watanabe, R., Tomita, N., Takeuchi, K., Sakata, S., Tateishi, U., Tanaka, M., Fujita, H., Inayama, Y., Ishigatsubo, Y.
SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma.
Leuk Lymphoma, 51, 279-283 (2010)

このページのTOPへ

2009

Ennishi, D., Yokoyama, M., Terui, Y., Asai, H., Sakajiri, S., Mishima, Y., Takahashi, S., Komatsu, H., Ikeda, K., Takeuchi, K., Tanimoto, M., Hatake, K.
Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy.
Ann Oncol, 20, 526-533 (2009)
Imai, H., Sugimoto, K., Isobe, Y., Sasaki, M., Yasuda, H., Takeuchi, K., Nakamura, S., Kojima, Y., Tomomatsu, J., Oshimi, K.
Absence of tumor-specific over-expression of Polo-like kinase 1 (Plk1) in major non-Hodgkin lymphoma and relatively low expression of Plk1 in nasal NK/T cell lymphoma.
Int J Hematol, 89, 673-678 (2009)
Inamura, K., Takeuchi, K., Togashi, Y., Hatano, S., Ninomiya, H., Motoi, N., Mun, M.Y., Sakao, Y., Okumura, S., Nakagawa, K., Soda, M., Choi, Y.L., Mano, H., Ishikawa, Y.
EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset.
Mod Pathol, 22, 508-515 (2009)
Kato, M., Sanada, M., Kato, I., Sato, Y., Takita, J., Takeuchi, K., Niwa, A., Chen, Y., Nakazaki, K., Nomoto, J., Asakura, Y., Muto, S., Tamura, A., Iio, M., Akatsuka, Y., Hayashi, Y., Mori, H., Igarashi, T., Kurokawa, M., Chiba, S., Mori, S., Ishikawa, Y., Okamoto, K., Tobinai, K., Nakagama, H., Nakahata, T., Yoshino, T., Kobayashi, Y., Ogawa, S.
Frequent inactivation of A20 in B-cell lymphomas.
Nature, 459, 712-716 (2009)
Kiryu, S., Takeuchi, K., Shibahara, J., Uozaki, H., Fukayama, M., Tanaka, H., Maeda, E., Akahane, M., Ohtomo, K.
Epstein-Barr virus-positive inflammatory pseudotumour and inflammatory pseudotumour-like follicular dendritic cell tumour.
Br J Radiol, 82, e67-71 (2009)
Masuda, S., Ageyama, N., Shibata, H., Obara, Y., Ikeda, T., Takeuchi, K., Ueda, Y., Ozawa, K., Hanazono, Y.
Cotransplantation with MSCs improves engraftment of HSCs after autologous intra-bone marrow transplantation in nonhuman primates.
Exp Hematol, 37, 1250-1257 e1251 (2009)
Mishima, Y., Sugimura, N., Matsumoto-Mishima, Y., Terui, Y., Takeuchi, K., Asai, S., Ennishi, D., Asai, H., Yokoyama, M., Kojima, K., Hatake, K.
An imaging-based rapid evaluation method for complement-dependent cytotoxicity discriminated clinical response to rituximab-containing chemotherapy.
Clin Cancer Res, 15, 3624-3632 (2009)
Nakamura, Y., Migita, T., Hosoda, F., Okada, N., Gotoh, M., Arai, Y., Fukushima, M., Ohki, M., Miyata, S., Takeuchi, K., Imoto, I., Katai, H., Yamaguchi, T., Inazawa, J., Hirohashi, S., Ishikawa, Y., Shibata, T.
Kruppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression.
Int J Cancer, 125, 1859-1867 (2009)
Takeuchi, K., Choi, Y.L., Togashi, Y., Soda, M., Hatano, S., Inamura, K., Takada, S., Ueno, T., Yamashita, Y., Satoh, Y., Okumura, S., Nakagawa, K., Ishikawa, Y., Mano, H.
KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer.
Clin Cancer Res, 15, 3143-3149 (2009)
Tanaka, Y., Ikeda, T., Kishi, Y., Masuda, S., Shibata, H., Takeuchi, K., Komura, M., Iwanaka, T., Muramatsu, S., Kondo, Y., Takahashi, K., Yamanaka, S., Hanazono, Y.
ERas is expressed in primate embryonic stem cells but not related to tumorigenesis.
Cell Transplant, 18, 381-389 (2009)
Terui, Y., Mishima, Y., Sugimura, N., Kojima, K., Sakurai, T., Kuniyoshi, R., Taniyama, A., Yokoyama, M., Sakajiri, S., Takeuchi, K., Watanabe, C., Takahashi, S., Ito, Y., Hatake, K.
Identification of CD20 C-terminal deletion mutations associated with loss of CD20 expression in non-Hodgkin's lymphoma.
Clin Cancer Res, 15, 2523-2530 (2009)
Tomita, N., Takeuchi, K., Hyo, R., Hashimoto, C., Takemura, S., Taguchi, J., Fujita, H., Fujisawa, S., Ogawa, K., Motomura, S., Ishigatsubo, Y.
Diffuse large B cell lymphoma without immunoglobulin light chain restriction by flow cytometry.
Acta Haematol, 121, 196-201 (2009)
Tomita, N., Tokunaka, M., Nakamura, N., Takeuchi, K., Koike, J., Motomura, S., Miyamoto, K., Kikuchi, A., Hyo, R., Yakushijin, Y., Masaki, Y., Fujii, S., Hayashi, T., Ishigatsubo, Y., Miura, I.
Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.
Haematologica, 94, 935-943 (2009)
Yano, S., Usui, N., Dobashi, N., Yahagi, Y., Takahara, S., Sugiyama, K., Ogasawara, Y., Saito, T., Minami, J., Kobayashi, T., Nikaido, T., Takeuchi, K., Aiba, K.
A case of primary esophageal mucosa-associated lymphoid tissue lymphoma with a numerical abnormality of 18q21 detected by fluorescence in situ hybridization.
Ann Hematol, 88, 703-704 (2009)
Yoshimura, K., Takeuchi, K., Nagasaki, K., Ogishima, S., Tanaka, H., Iwase, T., Akiyama, F., Kuroda, Y., Miki, Y.
Prognostic value of matrix Gla protein in breast cancer.
Mol Med Rep, 2, 549-553 (2009)

このページのTOPへ

2008

Choi, Y.L., Takeuchi, K., Soda, M., Inamura, K., Togashi, Y., Hatano, S., Enomoto, M., Hamada, T., Haruta, H., Watanabe, H., Kurashina, K., Hatanaka, H., Ueno, T., Takada, S., Yamashita, Y., Sugiyama, Y., Ishikawa, Y., Mano, H.
Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.
Cancer Res, 68, 4971-4976 (2008)
Ennishi, D., Takeuchi, K., Yokoyama, M., Asai, H., Mishima, Y., Terui, Y., Takahashi, S., Komatsu, H., Ikeda, K., Yamaguchi, M., Suzuki, R., Tanimoto, M., Hatake, K.
CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.
Ann Oncol, 19, 1921-1926 (2008)
Ennishi, D., Terui, Y., Yokoyama, M., Mishima, Y., Takahashi, S., Takeuchi, K., Ikeda, K., Tanimoto, M., Hatake, K.
Increased incidence of interstitial pneumonia by CHOP combined with rituximab.
Int J Hematol, 87, 393-397 (2008)
Ennishi, D., Terui, Y., Yokoyama, M., Mishima, Y., Takahashi, S., Takeuchi, K., Okamoto, H., Tanimoto, M., Hatake, K.
Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy.
Am J Hematol, 83, 59-62 (2008)
Ennishi, D., Yokoyama, M., Terui, Y., Takeuchi, K., Ikeda, K., Tanimoto, M., Hatake, K.
Does rituximab really induce hepatitis C virus reactivation?
J Clin Oncol, 26, 4695-4696; author reply 4696 (2008)
Inamura, K., Takeuchi, K., Togashi, Y., Nomura, K., Ninomiya, H., Okui, M., Satoh, Y., Okumura, S., Nakagawa, K., Soda, M., Choi, Y.L., Niki, T., Mano, H., Ishikawa, Y.
EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.
J Thorac Oncol, 3, 13-17 (2008)
Izawa, N., Matsumoto, S., Manabe, J., Tanizawa, T., Hoshi, M., Shigemitsu, T., Machinami, R., Kanda, H., Takeuchi, K., Miki, Y., Arai, M., Shirahama, S., Kawaguchi, N.
A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene.
Int J Clin Oncol, 13, 78-82 (2008)
Machinami, R., Nishida, K., Ishida, T., Matsumoto, S., Kuroda, K., Kobayashi, M., Takeuchi, K., Ishikawa, Y.
Carcinosarcomatous malignancy, osteosarcoma and squamous cell carcinoma, in giant cell tumor of the right distal femur.
Pathol Res Pract, 204, 583-588 (2008)
Soda, M., Takada, S., Takeuchi, K., Choi, Y.L., Enomoto, M., Ueno, T., Haruta, H., Hamada, T., Yamashita, Y., Ishikawa, Y., Sugiyama, Y., Mano, H.
A mouse model for EML4-ALK-positive lung cancer.
Proc Natl Acad Sci U S A, 105, 19893-19897 (2008)
Suzuki, N., Katsusihma, H., Takeuchi, K., Nakamura, S., Ishizawa, K., Ishii, S., Moriya, T., DeCoteau, J.F., Miura, I., Ichinohasama, R.
Cytogenetic abnormality 46,XX,add(21)(q11.2) in a patient with follicular dendritic cell sarcoma.
Cancer Genet Cytogenet, 186, 54-57 (2008)
Suzuki, R., Takeuchi, K., Ohshima, K., Nakamura, S.
Extranodal NK/T-cell lymphoma: diagnosis and treatment cues.
Hematol Oncol, 26, 66-72 (2008)
Takeuchi, K., Choi, Y.L., Soda, M., Inamura, K., Togashi, Y., Hatano, S., Enomoto, M., Takada, S., Yamashita, Y., Satoh, Y., Okumura, S., Nakagawa, K., Ishikawa, Y., Mano, H.
Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.
Clin Cancer Res, 14, 6618-6624 (2008)

このページのTOPへ

2007

Ennishi, D., Yokoyama, M., Mishima, Y., Watanabe, C., Terui, Y., Takahashi, S., Takeuchi, K., Ikeda, K., Tanimoto, M., Hatake, K.
Rituximab plus CHOP as an initial chemotherapy for patients with disseminated MALT lymphoma.
Leuk Lymphoma, 48, 2241-2243 (2007)
Isobe, Y., Sugimoto, K., Takeuchi, K., Ando, J., Masuda, A., Mori, T., Oshimi, K.
Neural cell adhesion molecule (CD56)-positive B-cell lymphoma.
Eur J Haematol, 79, 166-169 (2007)
Narimatsu, H., Ota, Y., Kami, M., Takeuchi, K., Suzuki, R., Matsuo, K., Matsumura, T., Yuji, K., Kishi, Y., Hamaki, T., Sawada, U., Miyata, S., Sasaki, T., Tobinai, K., Kawabata, M., Atsuta, Y., Tanaka, Y., Ueda, R., Nakamura, S.
Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients.
Ann Oncol, 18, 122-128 (2007)
Nitta, E., Izutsu, K., Sato, T., Ota, Y., Takeuchi, K., Kamijo, A., Takahashi, K., Oshima, K., Kanda, Y., Chiba, S., Motokura, T., Kurokawa, M.
A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study.
Ann Oncol, 18, 364-369 (2007)
Oyama, T., Yamamoto, K., Asano, N., Oshiro, A., Suzuki, R., Kagami, Y., Morishima, Y., Takeuchi, K., Izumo, T., Mori, S., Ohshima, K., Suzumiya, J., Nakamura, N., Abe, M., Ichimura, K., Sato, Y., Yoshino, T., Naoe, T., Shimoyama, Y., Kamiya, Y., Kinoshita, T., Nakamura, S.
Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients.
Clin Cancer Res, 13, 5124-5132 (2007)
Sakoda, Y., Hashimoto, D., Asakura, S., Takeuchi, K., Harada, M., Tanimoto, M., Teshima, T.
Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease.
Blood, 109, 1756-1764 (2007)
Shinohara, A., Asai, T., Izutsu, K., Ota, Y., Takeuchi, K., Hangaishi, A., Kanda, Y., Chiba, S., Motokura, T., Kurokawa, M.
Durable remission after the administration of rituximab for EBV-negative, diffuse large B-cell lymphoma following autologous peripheral blood stem cell transplantation for angioimmunoblastic T-cell lymphoma.
Leuk Lymphoma, 48, 418-420 (2007)
Tomita, N., Motomura, S., Hyo, R., Takasaki, H., Takemura, S., Taguchi, J., Fujisawa, S., Ogawa, K., Ishigatsubo, Y., Takeuchi, K.
Comparison of peripheral T-cell lymphomas and diffuse large B-cell lymphoma.
Cancer, 109, 1146-1151 (2007)

このページのTOPへ

2006

Hoshi, M., Matsumoto, S., Manabe, J., Tanizawa, T., Shigemitsu, T., Izawa, N., Takeuchi, K., Kawaguchi, N.
Malignant change secondary to fibrous dysplasia.
Int J Clin Oncol, 11, 229-235 (2006)
Hoshi, M., Matsumoto, S., Manabe, J., Tanizawa, T., Shigemitsu, T., Koyanagi, H., Ae, K., Takeuchi, K., Kawaguchi, N.
Surgery for dedifferentiated liposarcoma, presenting two radiologically and pathologically distinctive patterns.
Jpn J Clin Oncol, 36, 462-467 (2006)
Hoshi, M., Matsumoto, S., Manabe, J., Tanizawa, T., Shigemitsu, T., Takeuchi, K., Kawaguchi, N.
Report of four cases with high-grade surface osteosarcoma.
Jpn J Clin Oncol, 36, 180-184 (2006)
Hoshi, M., Matsumoto, S., Manabe, J., Tanizawa, T., Shigemitsu, T., Takeuchi, K., Kawaguchi, N.
Three cases with periosteal osteosarcoma arising from the femur.
J Orthop Sci, 11, 224-228 (2006)
Iwata, H., Matsuo, K., Hara, S., Takeuchi, K., Aoyama, T., Murashige, N., Kanda, Y., Mori, S., Suzuki, R., Tachibana, S., Yamane, M., Odawara, M., Mutou, Y., Kami, M.
Use of hydroxy-methyl-glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignancies.
Cancer Sci, 97, 133-138 (2006)
Kim, S.W., Tanimoto, T.E., Hirabayashi, N., Goto, S., Kami, M., Yoshioka, S., Uchida, T., Kishi, K., Tanaka, Y., Kohno, A., Kasai, M., Higuchi, M., Mori, S., Fukuda, T., Izutsu, K., Sao, H., Ishikawa, T., Ichinohe, T., Takeuchi, K., Tajima, K., Tanosaki, R., Harada, M., Taniguchi, S., Tobinai, K., Hotta, T., Takaue, Y.
Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan.
Blood, 108, 382-389 (2006)
Kiryu, S., Okubo, T., Takeuchi, K., Inoue, Y., Endo, T., Odawara, T., Nakamura, T., Aoki, S., Ohtomo, K.
Magnetic resonance imaging and diffusion tensor analysis of lymphomatoid granulomatosis of the brain.
Acta Radiol, 47, 509-513 (2006)
Mito, H., Kakizaki, H., Tsuji, H., Ide, A., Takeuchi, K., Takamura, H.
Peripheral T-cell lymphoma of the eyelid.
Jpn J Ophthalmol, 50, 388-390 (2006)
Shi, X., Matsumoto, S., Manbe, J., Tanizawa, T., Hoshi, M., Sigemitsu, T., Izawa, N., Takeuchi, K., Kawaguchi, N.
Long-term survival of soft tissue sarcoma patients with extrapulmonary metastasis.
J Orthop Sci, 11, 92-96 (2006)
Takeuchi, K., Tanaka-Taya, K., Kazuyama, Y., Ito, Y.M., Hashimoto, S., Fukayama, M., Mori, S.
Prevalence of Epstein-Barr virus in Japan: trends and future prediction.
Pathol Int, 56, 112-116 (2006)

このページのTOPへ